Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc at Stifel Healthcare Conference (Virtual) Transcript

Nov 17, 2021 / 09:00PM GMT
Release Date Price: €124.65 (+3.32%)
Mathew Justin Blackman
Stifel, Nicolaus & Company, Incorporated, Research Division - Analyst

All right. Hello, everybody. Welcome to my final session of the 2021 Stifel Virtual Healthcare Conference. I'm Mathew Blackman, as a reminder, one of the senior medtech analysts here at Stifel.

And for this session, we're thrilled to have the management of Tandem Diabetes, the leader today at the automated insulin delivery revolution we're seeing in the diabetes marketplace, not only here in the United States, but across the world. We have joining us today, Leigh Vosseller, Executive Vice President and CFO; and Susan Morrison, Chief Administrative Officer and Executive Vice President. Thank you so much for, again, participating this year.

And everyone in the audience, this is a fireside-chat format meant to be interactive. And so if you have questions, please do not hesitate. Type them in the question box on your screen, and we'll do our best to address them when and where relevant.

So little bit of an intro. I'm going to give you a sense of what we're going to try to tackle today

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot